Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about BRISTOL-MYERS SQUIBB COMPANY
09/20BRISTOL MYERS SQUIBB : FDA Grants Bristol-Myers Squibb Priority Review for Metastatic Mela..
MT
09/20BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Review Brist..
BU
09/20Bristol Myers Squibb Announces FDA Accepts for Priority Review Biologics License Applic..
CI
09/20Bristol Myers Gets FDA Priority Review of Relatlimab/Opdivo Combo in Melanoma
DJ
09/17BRISTOL MYERS SQUIBB : Combination Therapy Gets EMA Committee's Backing for Treating Gastr..
MT
09/17BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherap..
BU
09/17Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo with Chemotherapy for Pa..
CI
09/17Bristol Myers Gets Positive CHMP Opinion for Opdivo in Gastric, Esophageal Cancers
DJ
09/16Bristol-Myers Squibb Down Nine Consecutive Days, on Pace for Longest Losing Streak Sinc..
DJ
09/16BRISTOL MYERS SQUIBB : Reports Data From Phase 3 Trial of Opdivo, Yervoy Combination
MT
09/16BRISTOL MYERS SQUIBB : Five-Year Data from CheckMate -214 Show Opdivo (nivolumab) Plus Yer..
BU
09/16Bristol Myers Squibb Announces Five-Year Data from Checkmate -214 Show Opdivo Plus Yerv..
CI
09/13BRISTOL MYERS SQUIBB : Says Phase 3 Trial of Opdivo Combined With Yervoy for Organ Tissue ..
MT
09/13BRISTOL MYERS SQUIBB : According to New Multinational Survey, Healthcare Providers Believe..
BU
09/13BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Durable Ov..
BU
More most relevant news
All news about BRISTOL-MYERS SQUIBB COMPANY
09/20BRISTOL MYERS SQUIBB : FDA Grants Bristol-Myers Squibb Priority Review for Metastatic Mela..
MT
09/20BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Review Brist..
BU
09/20Bristol Myers Squibb Announces FDA Accepts for Priority Review Biologics License Applic..
CI
09/20Bristol Myers Gets FDA Priority Review of Relatlimab/Opdivo Combo in Melanoma
DJ
09/17BRISTOL MYERS SQUIBB : Combination Therapy Gets EMA Committee's Backing for Treating Gastr..
MT
09/17BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherap..
BU
09/17Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo with Chemotherapy for Pa..
CI
09/17Bristol Myers Gets Positive CHMP Opinion for Opdivo in Gastric, Esophageal Cancers
DJ
09/16Bristol-Myers Squibb Down Nine Consecutive Days, on Pace for Longest Losing Streak Sinc..
DJ
09/16BRISTOL MYERS SQUIBB : Reports Data From Phase 3 Trial of Opdivo, Yervoy Combination
MT
More news
News in other languages on BRISTOL-MYERS SQUIBB COMPANY
09/16Exelixis déclare que de nouvelles données exploratoires issues d'un essai de phase avan..
09/09Bristol Myers Squibb annonce le versement d'un dividende trimestriel, payable le 1er no..
09/07Pharma-Industrie geht von ausreichend Corona-Impfstoff für alle aus
09/03Sandoz Canada, filiale de Novartis, lance une version générique du médicament contre le..
09/02Evotec erhält weitere Meilensteinzahlung von Bristol-Myers Squibb
09/02Bristol Myers zieht Option für Lizenzvereinbarung mit Evotec
08/03Wuxi-Gruppe schliesst Übernahme der Pharmaproduktion in Couvet ab
07/28US-Pharmakonzern Bristol-Myers Squibb erholt sich von Corona - starker Umsatz
07/28BRISTOL-MYERS : croissance de 18% du BPA trimestriel
07/16BRISTOL MYERS : échec dans le cancer de la tête et du cou
More news
Analyst Recommendations on BRISTOL-MYERS SQUIBB COMPANY
07/29BRISTOL MYERS SQUIBB : Goldman Sachs Adjusts Price Target for Bristol-Myers Squibb to $94 ..
MT
07/29BRISTOL MYERS SQUIBB : Morgan Stanley Lifts Price Target on Bristol-Myers Squibb to $71 Fr..
MT
04/30BRISTOL MYERS SQUIBB : Morgan Stanley Cuts Bristol-Myers Squibb to Equal-Weight From Overw..
MT
04/13BRISTOL MYERS SQUIBB : Truist Securities Upgrades Bristol-Myers Squibb to Buy From Hold
MT
03/17BRISTOL MYERS SQUIBB : BofA Notes Bristol-Myers Squibb's $20 Billion Product Cycle Revenue..
MT
More recommendations
Press releases
09/20BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts for Priority Review Brist..
BU
09/17BRISTOL MYERS SQUIBB : Receives Positive CHMP Opinion for Opdivo (nivolumab) + Chemotherap..
BU
09/16BRISTOL MYERS SQUIBB : Five-Year Data from CheckMate -214 Show Opdivo (nivolumab) Plus Yer..
BU
09/13BRISTOL MYERS SQUIBB : According to New Multinational Survey, Healthcare Providers Believe..
BU
09/13BRISTOL MYERS SQUIBB : Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates Durable Ov..
BU
More press releases
Upcoming event on BRISTOL-MYERS SQUIBB COMPANY
09/30/21